Programmed death-1 targeting can promote allograft survival.
Ozkaynak E, Wang L, Goodearl A, McDonald K, Qin S, O'Keefe T, Duong T, Smith T, Gutierrez-Ramos JC, Rottman JB, Coyle AJ, Hancock WW.
Ozkaynak E, et al. Among authors: wang l.
J Immunol. 2002 Dec 1;169(11):6546-53. doi: 10.4049/jimmunol.169.11.6546.
J Immunol. 2002.
PMID: 12444166